| Financial Year |
March 31 2023 |
| Monetary Funds |
120,040,853.58 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
50,391,325.23 |
| Advances to Suppliers |
48,438,041.23 |
| Other Receivables |
7,448,580.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
45,002,882.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
206,950,667.78 |
| Total Current Assets |
478,272,350.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
14,346,018.92 |
| Fixed Assetes |
1,898,523,023.11 |
| Under-construction Projects |
111,486,680.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,124,645.11 |
| Deferred Income Tax Assets |
14,543,377.95 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,047,318,942.56 |
| Total Assets |
2,525,591,292.70 |
| Short-Term Loans |
493,450,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
374,000,000.00 |
| Accounts Payable |
189,563,945.79 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
110,079.20 |
| Taxes Payable |
6,380,524.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
24,741,954.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
45,555,654.37 |
| Other Current Liabilities |
1,132,322.11 |
| Sub-Total of Current Liabilities |
1,161,020,532.25 |
| Long-term Loans |
924,086,713.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,136,381.35 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
971,761,411.20 |
| Total Liabilities |
2,132,781,943.45 |
| Paid-In Capital(Or Share Stock) |
404,599,600.00 |
| Capital Surplus |
102,173,294.67 |
| Surplus Reserve |
174,324,202.47 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-290,803,213.65 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
392,809,349.25 |
| Owner's Equity（Stockholder's Equity） |
392,809,349.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,525,591,292.70 |
